Definitive Healthcare (NasdaqGS:DH) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsCasey Heller - CFOJonathan Paris - Chief Legal Officer and SecretaryKevin Coop - CEO and Board MemberConference Call ParticipantsBrian Peterson - Managing Director and Senior Equity Research AnalystGeorge Hill - Managing Director and Senior Equity Research AnalystJared Haase - Equity Research AnalystJeff Garro - Equity Research AnalystMatt Shea - Equity Research AnalystNone - AnalystJonathan ParisGood ...

Definitive Healthcare (NasdaqGS:DH) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Speaker5Good afternoon. Thank you for joining us today to review Definitive Healthcare's financial results. Joining me on the call today are Kevin Coop, Chief Executive Officer, and Casey Heller, Chief Financial Officer. During this call, we will make forward-looking statements, including, but not limited to, statements related to our market and future performance and growth opportunities, the benefits of our differentia ...

Definitive Healthcare FY Conference Summary Company Overview - **Company**: Definitive Healthcare (NasdaqGS:DH) - **Industry**: Healthcare market data and analytics - **Business Model**: Proprietary SaaS platform serving three customer groups: life sciences, healthcare providers, and diversified clients [5][6] Key Financial Metrics - **Recurring Revenue**: Approximately 95% of revenue is recurring [6] - **Adjusted EBITDA Margins**: High 20s percentage [6] - **Cash Flow Conversion**: Vast majority of Adjusted EBIT converted into cash flow [6] Strategic Pillars 1. **Data Differentiation** - Focus on reference and affiliation data as a foundational component for understanding the healthcare ecosystem [12] - New data sets added, including mobile phone numbers for healthcare executives and new claims data sources [12][13] - Significant KPI tracking implemented to measure data quality and completeness [13] 2. **Seamless Integration** - Progress made in integrating acquired companies into a unified platform [19] - Customer retention rates are approximately 15 points higher for integrated customers [20] - New integrations launched, including HubSpot and additional physician data into Salesforce [20][21] 3. **Customer Success** - Focus on improving customer engagement and retention metrics [25] - Customer success incentive plans aligned with gross and net dollar retention [26] - Win-back strategy for previous customers, emphasizing value-based selling [28][29] 4. **Innovation and Digital Partnerships** - Generative AI is a key focus area for both internal operations and product development [30][33] - Agency partnerships have grown to about 23, with ongoing activations [36][38] - Emphasis on leveraging agency relationships to expand market reach [40][41] Market Segments - **Revenue Breakdown**: 40% from life sciences, 10% from providers, and 50% from diversified clients [45] - **Life Sciences Challenges**: Cautious outlook due to budgetary constraints and downsell pressures [45][46] - **Sales Cycle Trends**: Notable tightening of sales cycles observed, indicating potential for improved demand [46] Capital Allocation Strategy - **Cash Position**: Over $185 million in cash on the balance sheet, with net zero leverage [61] - **Investment Focus**: Prioritizing organic investments that strengthen core offerings and enhance customer value [61][62] - **M&A Strategy**: High bar for future acquisitions, with a focus on adjacent growth areas [62] Additional Insights - **Operational Efficiency**: Continuous evaluation of operational expenses, particularly in G&A and sales/marketing [56][57] - **AI Utilization**: Exploring AI tools to improve productivity and customer engagement [54][55] - **Customer Engagement**: Emphasis on understanding customer health scores and engagement levels to drive retention [27] This summary encapsulates the key points discussed during the Definitive Healthcare FY Conference, highlighting the company's strategic focus, financial metrics, and market dynamics.